You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GVAX

Showing 1 - 25 of 41
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Pancreatic Adenocarcinoma Trial in Baltimore (Epacadostat, Pembrolizumab, CRS-207)

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 3, 2023

Neuroblastoma, Pediatric Solid Tumor Trial in Boston (procedure, biological, drug)

Recruiting
  • Neuroblastoma
  • Pediatric Solid Tumor
  • Tissue collection
  • +3 more
  • Boston, Massachusetts
  • +1 more
Oct 17, 2022

Pancreatic Cancer Trial in Baltimore (Cyclophosphamide, GVAX, Pembrolizumab)

Active, not recruiting
  • Pancreatic Cancer
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Jan 5, 2023

Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Boston (biological, procedure, drug)

Terminated
Has Results
  • Myelodysplastic Syndrome
  • +2 more
  • GVAX
  • +6 more
  • Boston, Massachusetts
  • +3 more
Jun 30, 2022

Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC), Pancreatic Ductal Adenocarcinoma Trial in Baltimore (Stereotactic Body

Recruiting
  • Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)
  • Pancreatic Ductal Adenocarcinoma
  • Stereotactic Body Radiation (SBRT)
  • +3 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Jan 28, 2022

Pancreatic Cancer Trial in Baltimore, Milwaukee (Cyclophosphamide, Nivolumab, GVAX Pancreas Vaccine)

Active, not recruiting
  • Pancreatic Cancer
  • Baltimore, Maryland
  • +1 more
Mar 3, 2022

Pancreatic Cancer Trial in Baltimore (drug, biological, radiation)

Active, not recruiting
  • Pancreatic Cancer
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mar 3, 2022

Metastatic Colorectal Cancer Trial in Baltimore (CY, GVAX, SGI-110)

Completed
  • Metastatic Colorectal Cancer
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mar 26, 2021

Previously Treated Metastatic Adenocarcinoma of the Pancreas Trial in United States (CRS-207, nivolumab, GVAX)

Completed
Has Results
  • Previously Treated Metastatic Adenocarcinoma of the Pancreas
  • CRS-207
  • +3 more
  • San Francisco, California
  • +4 more
Mar 17, 2021

Metastatic Colorectal Cancer Trial in Baltimore (CY, GVAX, Pembrolizumab)

Completed
Has Results
  • Metastatic Colorectal Cancer
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Feb 8, 2021

Multiple Myeloma Trial in Baltimore (biological, drug, other)

Recruiting
  • Multiple Myeloma
  • GM-CSF vaccine
  • +4 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 6, 2022

Sarcoma, Clear Cell, Sarcoma, Alveolar Soft Part, Renal Cell Carcinoma Trial in Boston (GVAX)

Completed
  • Sarcoma, Clear Cell
  • +3 more
  • GVAX
  • Boston, Massachusetts
  • +1 more
Mar 2, 2021

Myelodysplastic Syndrome RAEB-I or RAEB-II, Refractory Acute Myeloid Leukemia, Refractory CML Myeloid Blast Crisis Trial in

Completed
  • Myelodysplastic Syndrome RAEB-I or RAEB-II
  • +2 more
  • GM-CSF secreting leukemia vaccine
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 28, 2022

Metastatic Pancreatic Adenocarcinoma Trial in San Francisco, Baltimore, Saint Louis (Ipilimumab, Vaccine, FOLFIRINOX)

Completed
Has Results
  • Metastatic Pancreatic Adenocarcinoma
  • San Francisco, California
  • +2 more
May 5, 2020

Colorectal Cancer, Metastatic Cancer Trial in Baltimore (Colon GVAX, cyclophosphamide)

Completed
  • Colorectal Cancer
  • Metastatic Cancer
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Aug 12, 2019

Pancreatic Cancer Trial in Baltimore (Cetuximab, Pancreatic tumor vaccine, Cyclophosphamide)

Completed
Has Results
  • Pancreatic Cancer
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Feb 10, 2020

Pancreatic Cancer Trial in Baltimore (GVAX pancreatic cancer vaccine, cyclophosphamide)

Completed
Has Results
  • Pancreatic Cancer
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Feb 12, 2020

Prostate Cancer Adenocarcinoma in Situ Trial in Baltimore (degarelix acetate, Cyclophosphamide, GVAX)

Completed
Has Results
  • Prostate Cancer Adenocarcinoma in Situ
  • degarelix acetate
  • +2 more
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mar 18, 2019

Ewings Sarcoma, Non Small Cell Lung Cancer, Liver Cancer Trial in United States (Vigil™)

Completed
  • Ewings Sarcoma
  • +2 more
  • Vigil™
  • West Palm Beach, Florida
  • +3 more
Mar 14, 2022

Metastatic Pancreatic Cancer Trial in United States (GVAX Pancreas, CRS-207, Cyclophosphamide)

Completed
Has Results
  • Metastatic Pancreatic Cancer
  • GVAX Pancreas
  • +2 more
  • Tampa, Florida
  • +9 more
Apr 6, 2018

Multiple Myeloma Trial in Baltimore (GVAX, Autologous transplant)

Completed
  • Multiple Myeloma
  • GVAX
  • Autologous transplant
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sep 17, 2018

Colorectal Cancer Trial in Boston (GVAX)

Recruiting
  • Colorectal Cancer
  • GVAX
  • Boston, Massachusetts
    Massachusetts General Hospital
Jan 4, 2018

Mesolthelioma, Esophageal Cancer, Lung Cancer Trial run by the NCI (Celebrex, Tumor cell vaccine)

Terminated
  • Mesolthelioma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 30, 2019

Multiple Myeloma Trial in Baltimore (Lenalidomide, Allogeneic Myeloma Vaccine, Prevnar-13)

Completed
Has Results
  • Multiple Myeloma
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 14, 2019

Metastatic Pancreatic Adenocarcinoma Trial in Washington (LEE011, Everolimus)

Unknown status
  • Metastatic Pancreatic Adenocarcinoma
  • Washington, District of Columbia
    Lombardi Comprehensive Cancer Center
May 20, 2019